Kairos Pharma, Ltd.(KAPA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KAPA Kairos Pharma, Ltd.

交易中 12-31 11:52:15 EST

0.7089

+0.0091

+1.30%

最高0.7090	最低0.6801	成交量7.50万
今开0.6801	昨收0.6998	日振幅4.13%
总市值1,476万	流通市值109.88万	总股本2,082万
成交额5.22万	换手率4.84%	流通股本155.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KAPA","market":"US","secType":"STK","nameCN":"Kairos Pharma, Ltd.","latestPrice":0.7089,"timestamp":1767199571419,"preClose":0.6998,"halted":0,"volume":74971,"delay":0,"floatShares":1550000,"shares":20821353,"eps":-0.30563,"marketStatus":"交易中","change":0.0091,"latestTime":"12-31 11:52:15 EST","open":0.6801,"high":0.709,"low":0.6801,"amount":52230.671828139995,"amplitude":0.041298,"askPrice":0.71,"askSize":800,"bidPrice":0.6927,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.30563,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1767214800000},"marketStatusCode":2,"adr":0,"listingDate":1717992000000,"exchange":"NASDAQ","adjPreClose":0.6998,"preHourTrading":{"tag":"盘前","latestPrice":0.694,"preClose":0.6998,"latestTime":"09:17 EST","volume":1294,"amount":898.3230092,"timestamp":1767190652778},"postHourTrading":{"tag":"盘后","latestPrice":0.693,"preClose":0.6998,"latestTime":"19:06 EST","volume":7681,"amount":5339.2512,"timestamp":1767139590424},"volumeRatio":0.960471},"requestUrl":"/m/hq/s/KAPA","defaultTab":"news","newsList":[{"id":"2582313405","title":"Kairos Pharma, Ltd.盘中异动 早盘股价大跌5.06%报0.881美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582313405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582313405?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:43","pubTimestamp":1762872230,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日22时43分，Kairos Pharma, Ltd.股票出现异动，股价大幅跳水5.06%。截至发稿，该股报0.881美元/股，成交量2595股，换手率0.01%，振幅0.00%。Kairos Pharma, Ltd.股票所在的生物技术行业中，整体涨幅为0.18%。Kairos Pharma, Ltd.公司简介：Kairos Pharma Ltd 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511112243509762b5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511112243509762b5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","KAIR","BK4139"],"gpt_icon":0},{"id":"1109723454","title":"Kairos Pharma将在2025年ESMO大会上公布前列腺癌二期试验积极的安全性和疗效数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1109723454","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109723454?lang=zh_cn&edition=full","pubTime":"2025-10-07 20:02","pubTimestamp":1759838561,"startTime":"0","endTime":"0","summary":"Kairos Pharma将在2025年ESMO大会上展示其前列腺癌二期临床试验取得的积极安全性和疗效数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"1152471483","title":"Kairos Pharma宣布Env105治疗晚期前列腺癌2期试验积极中期疗效分析结果，中位无进展生存期超过一年","url":"https://stock-news.laohu8.com/highlight/detail?id=1152471483","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152471483?lang=zh_cn&edition=full","pubTime":"2025-09-18 20:04","pubTimestamp":1758197053,"startTime":"0","endTime":"0","summary":"Kairos Pharma宣布其药物Env105治疗晚期前列腺癌的2期临床试验取得积极的中期疗效分析结果，患者中位无进展生存期超过一年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"1105900764","title":"Kairos Pharma, Ltd.宣布举办虚拟专家活动 分享Env105治疗晚期前列腺癌中期疗效数据见解","url":"https://stock-news.laohu8.com/highlight/detail?id=1105900764","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105900764?lang=zh_cn&edition=full","pubTime":"2025-09-11 20:00","pubTimestamp":1757592053,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd.宣布将举办虚拟专家活动，邀请行业意见领袖分享对其候选药物Env105在晚期前列腺癌治疗中期疗效结果的专业见解和观点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"1172809087","title":"Kairos Pharma宣布将在2025年9月6-9日世界肺癌大会上展示Env105联合疗法治疗非小细胞肺癌的最新一期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1172809087","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172809087?lang=zh_cn&edition=full","pubTime":"2025-09-03 20:15","pubTimestamp":1756901727,"startTime":"0","endTime":"0","summary":"Kairos Pharma宣布将在2025年9月6-9日举行的世界肺癌大会上展示其Env105联合疗法治疗非小细胞肺癌的最新一期临床试验数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2553293758","title":"Kairos Pharma, Ltd.7月22日成交额为71.92万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553293758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553293758?lang=zh_cn&edition=full","pubTime":"2025-07-23 11:07","pubTimestamp":1753240039,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Kairos Pharma, Ltd.成交额为71.92万美元，成交额较昨日减少39.04%，当日成交量为72.28万股。Kairos Pharma, Ltd.于2025年7月22日涨1.98%，报1.03美元，该股过去5个交易日跌11.97%，年初至今跌32.24%，过去60日涨20.75%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-22|71.92万|-39.04%|72.28万|#|2025-07-21|117.98万|-73.57%|110.71万|#|2025-07-18|446.45万|19.23%|400.57万|#|2025-07-17|374.46万|-59.65%|357.40万|#|2025-07-16|927.95万|-97.07%|878.07万|Kairos Pharma Ltd 是一家处于临床阶段的生物制药公司。该公司从事癌症患者的治疗，旨在克服免疫抑制和耐药性的关键障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723110721a6bc402f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723110721a6bc402f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAPA","KAIR"],"gpt_icon":0},{"id":"2551195585","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551195585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551195585?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:57","pubTimestamp":1752591459,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时57分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.15%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715225739a44cb0f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715225739a44cb0f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","ZNTL","BK4139","KAIR"],"gpt_icon":0},{"id":"2551021193","title":"Alector, Inc.盘中异动 早盘急速跳水5.09%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551021193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551021193?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:53","pubTimestamp":1752591190,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时53分，Alector, Inc.股票出现异动，股价急速跳水5.09%。截至发稿，该股报1.59美元/股，成交量7.9256万股，换手率0.08%，振幅5.99%。Alector, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Kairos Pharma, Ltd.、Polyrizon Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为1651.12%、1508.01%、1079.05%，振幅较大的相关个股有Kairos Pharma, Ltd.、Polyrizon Ltd.、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为109.47%、75.50%、66.39%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715225310a44caf39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715225310a44caf39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","BK4139","KAIR","ALEC"],"gpt_icon":0},{"id":"2551931451","title":"Omniab, Inc.盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551931451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551931451?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:41","pubTimestamp":1752590461,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时41分，Omniab, Inc.股票出现波动，股价快速下挫5.37%。截至发稿，该股报1.94美元/股，成交量9.722万股，换手率0.08%，振幅6.83%。Omniab, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Kairos Pharma, Ltd.、Polyrizon Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Polyrizon Ltd.、Kairos Pharma, Ltd.较为活跃，换手率分别为1500.62%、1475.08%、1059.11%，振幅较大的相关个股有Kairos Pharma, Ltd.、Polyrizon Ltd.、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为109.47%、75.50%、66.39%。Omniab, Inc.公司简介：OmniAb Inc 提供治疗性抗体发现技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715224102a44caa4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715224102a44caa4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAIR","KAPA","BK4121","OABI"],"gpt_icon":0},{"id":"2551193117","title":"Maravai Lifesciences Holdings, Inc.盘中异动 早盘大幅跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551193117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551193117?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:39","pubTimestamp":1752590395,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时39分，Maravai Lifesciences Holdings, Inc.股票出现异动，股价快速下挫5.06%。Maravai Lifesciences Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Maravai Lifesciences Holdings, Inc.公司简介：Maravai LifeSciences Holdings Inc 是一家生命科学公司，提供关键产品，推动突破性疫苗、药物疗法、细胞和基因疗法以及诊断的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152239559543998d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152239559543998d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAIR","BK4121","KAPA","BK4139","MRVI"],"gpt_icon":0},{"id":"2551835193","title":"Gossamer Bio, Inc.盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551835193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551835193?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:17","pubTimestamp":1752589047,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时17分，Gossamer Bio, Inc.股票出现异动，股价急速下挫5.20%。截至发稿，该股报1.45美元/股，成交量52.4741万股，换手率0.23%，振幅4.90%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Polyrizon Ltd.、Kairos Pharma, Ltd.较为活跃，换手率分别为1482.70%、1259.54%、973.56%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为160.42%、91.96%、75.50%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221727a44ca050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221727a44ca050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAIR","BK4505","BK4139","GOSS","KAPA"],"gpt_icon":0},{"id":"2551981521","title":"Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)盘中异动 早盘股价大跌9.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551981521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551981521?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:11","pubTimestamp":1752588705,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时11分，Geovax Labs Inc C/Wts 29/09/2025股票出现波动，股价大幅跳水9.64%。Geovax Labs Inc C/Wts 29/09/2025股票所在的生物技术行业中，整体涨幅为0.23%。Geovax Labs Inc C/Wts 29/09/2025公司简介：Geovax Labs Inc 是一家临床阶段的生物技术公司，使用新颖的专有平台开发针对传染病和实体瘤癌症的人类疫苗和免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221145a6ab6683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715221145a6ab6683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","GOVXW","BK4139","KAIR"],"gpt_icon":0},{"id":"2551198464","title":"Nanobiotix盘中异动 早盘股价大涨6.60%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551198464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551198464?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:03","pubTimestamp":1752588214,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时03分，Nanobiotix股票出现波动，股价快速拉升6.60%。截至发稿，该股报5.49美元/股，成交量1290股，换手率0.00%，振幅0.19%。Nanobiotix股票所在的生物技术行业中，整体涨幅为0.51%。Nanobiotix公司简介：Nanobiotix SA 是一家临床阶段的生物技术公司，拥有一个运营部门，专注于开发候选产品，利用其专有的纳米技术通过提高放射治疗的疗效来改变癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715220334a44c9a0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715220334a44c9a0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","NBTX","BK4139","KAIR"],"gpt_icon":0},{"id":"2551919828","title":"美国OTC市场Scorpius Holdings, Inc.盘中异动 大幅上涨8.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551919828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551919828?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:51","pubTimestamp":1752587504,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时51分，美国OTC市场Scorpius Holdings, Inc.股票出现异动，股价快速上涨8.08%。截至发稿，该股报0.056美元/股，成交量5181股，换手率0.01%，振幅8.08%。美国OTC市场Scorpius Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。美国OTC市场Scorpius Holdings, Inc.公司简介：Scorpius Holdings Inc 是一家综合合同开发和制造组织 ，专注于将生物和细胞治疗项目快速推进到临床及其他领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715215144a44c950c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715215144a44c950c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCPX","BK4139","KAPA","KAIR","CDMO"],"gpt_icon":0},{"id":"2551607551","title":"Abvc Biopharma, Inc.盘中异动 早盘股价大跌5.41%报3.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551607551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551607551?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:40","pubTimestamp":1752586823,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时40分，Abvc Biopharma, Inc.股票出现波动，股价快速跳水5.41%。截至发稿，该股报3.32美元/股，成交量6.6335万股，换手率0.39%，振幅7.98%。Abvc Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Abvc Biopharma, Inc.公司简介：ABVC BioPharma Inc 是一家临床阶段生物制药公司，目前正在开发六种药物和一种医疗器械。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715214023a44c8ffd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715214023a44c8ffd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVC","BK4139","KAPA","KAIR"],"gpt_icon":0},{"id":"2551319337","title":"Tharimmune, Inc.盘中异动 早盘股价大涨6.51%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551319337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551319337?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:34","pubTimestamp":1752586447,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时34分，Tharimmune, Inc.股票出现波动，股价大幅拉升6.51%。截至发稿，该股报1.80美元/股，成交量2.6915万股，换手率0.64%，振幅3.18%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715213407a6ab56a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715213407a6ab56a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","KAIR","THAR","PBC","BK4139"],"gpt_icon":0},{"id":"2551216099","title":"Mimedx Group, Inc盘中异动 早盘急速下跌9.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551216099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551216099?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:31","pubTimestamp":1752586298,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时31分，Mimedx Group, Inc股票出现异动，股价快速下挫9.85%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Kairos Pharma, Ltd.、Polyrizon Ltd.、Prokidney Corp.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.较为活跃，换手率分别为1325.63%、691.58%、315.72%，振幅较大的相关个股有Kairos Pharma, Ltd.、Humacyte Inc C/Wts 27/08/2026 、Onkure Therapeutics, Inc.，振幅分别为35.03%、21.10%、10.16%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715213138a44c8c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715213138a44c8c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAIR","KAPA","BK4139","MDXG"],"gpt_icon":0},{"id":"2503655592","title":"Cosciens Biopharma Inc.盘中异动 快速下跌6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503655592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503655592?lang=zh_cn&edition=full","pubTime":"2025-01-14 04:57","pubTimestamp":1736801859,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日04时57分，Cosciens Biopharma Inc.股票出现波动，股价快速跳水6.47%。截至发稿，该股报3.18美元/股，成交量3143股，换手率0.10%，振幅4.71%。Cosciens Biopharma Inc.股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为16045.66%、8271.05%、876.89%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114045739a220990e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114045739a220990e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAPA","KAIR","CSCI"],"gpt_icon":0},{"id":"2503721553","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.11%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503721553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503721553?lang=zh_cn&edition=full","pubTime":"2025-01-14 04:56","pubTimestamp":1736801791,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日04时56分，Nautilus Biotechnology, Inc.股票出现异动，股价快速上涨5.11%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为16033.67%、8260.93%、876.67%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114045631aba98ab9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114045631aba98ab9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT","KAIR","KAPA","BK4139"],"gpt_icon":0},{"id":"2503558257","title":"Pmgc Holdings Inc.盘中异动 下午盘快速上涨5.21%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503558257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503558257?lang=zh_cn&edition=full","pubTime":"2025-01-14 04:29","pubTimestamp":1736800161,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日04时29分，Pmgc Holdings Inc.股票出现异动，股价快速上涨5.21%。截至发稿，该股报2.17美元/股，成交量15.3633万股，换手率5.00%，振幅9.42%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为15690.78%、8073.42%、858.60%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140429219602870a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140429219602870a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","BK4183","ELAB","KAIR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kairospharma.com","stockEarnings":[{"period":"1week","weight":-0.0694},{"period":"1month","weight":-0.1606},{"period":"3month","weight":-0.3807},{"period":"6month","weight":0.075},{"period":"1year","weight":-0.5514},{"period":"ytd","weight":-0.5396}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0053},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.0986},{"period":"1year","weight":0.1679},{"period":"ytd","weight":0.1722}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kairos Pharma, Ltd.于2013年6月17日根据加利福尼亚州法律注册成立，名称为NanoGB13, Inc.，随后于2023年5月10日转换为特拉华州公司，名称为Kairos Pharma, Ltd.。该公司是一家临床阶段的生物制药公司，致力于为癌症患者提供治疗，旨在克服免疫抑制和耐药性方面的关键障碍。这些疗法包括用于治疗前列腺癌、肺癌、乳腺癌和胶质母细胞瘤的抗体和小分子。","exchange":"NASDAQ","name":"Kairos Pharma, Ltd.","nameEN":"Kairos Pharma, Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kairos Pharma, Ltd.(KAPA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kairos Pharma, Ltd.(KAPA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kairos Pharma, Ltd.,KAPA,Kairos Pharma, Ltd.股票,Kairos Pharma, Ltd.股票老虎,Kairos Pharma, Ltd.股票老虎国际,Kairos Pharma, Ltd.行情,Kairos Pharma, Ltd.股票行情,Kairos Pharma, Ltd.股价,Kairos Pharma, Ltd.股市,Kairos Pharma, Ltd.股票价格,Kairos Pharma, Ltd.股票交易,Kairos Pharma, Ltd.股票购买,Kairos Pharma, Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kairos Pharma, Ltd.(KAPA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kairos Pharma, Ltd.(KAPA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}